Resveratrol Ameliorates Experimental Autoimmune Myocarditis

  • Yoshida Yuki
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Shioi Tetsuo
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Izumi Tohru
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine

この論文をさがす

抄録

Background Myosin-induced autoimmune myocarditis of rats is a model of human dilated cardiomyopathy. Resveratrol is a natural polyphenol found in grapes and wine that is reported to have cardioprotective and immunomodulatory effects. Methods and Results To examine the effect of resveratrol on myocarditis, vehicle or resveratrol (50 mg/kg per day) was administered to cardiac myosin immunized rats 1 day before the immunization. At 14 days after immunization, resveratrol had preserved cardiac function of myosin-immunized rats according to echocardiographic analysis. The heart weight/tibial length ratio of vehicle-treated myosin-immunized rats was increased by 1.8-fold compared with unimmunized rats, and resveratrol attenuated the heart weight increase. Resveratrol significantly decreased cellular infiltration, fibrosis, and expression of inflammatory cytokines in the myocardium. Expressions of antioxidant genes were increased in myosin-immunized hearts, and resveratrol decreased those expressions. Resveratrol also attenuated myocarditis 21 days after immunization. SIRT1, a potential effector of resveratrol, was increased in the myocardium of myosin-immunized rats compared with unimmunized rats. The SIRT1 protein was localized mainly in infiltrating mononuclear cells. Conclusions Resveratrol significantly ameliorated myocardial injury and preserved cardiac function in a rat model of autoimmune myocarditis. Resveratrol may be a therapeutic modality for myocarditis. (Circ J 2007; 71: 397 - 404)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 71 (3), 397-404, 2007

    一般社団法人 日本循環器学会

被引用文献 (3)*注記

もっと見る

参考文献 (48)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ